These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 24760750

  • 1. Renal, gastrointestinal, and hepatic late effects in survivors of childhood acute myeloid leukemia treated with chemotherapy only--a NOPHO-AML study.
    Skou AS, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology.
    Pediatr Blood Cancer; 2014 Sep; 61(9):1638-43. PubMed ID: 24760750
    [Abstract] [Full Text] [Related]

  • 2. Quality of health in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros-Svennilson J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1222-9. PubMed ID: 22095929
    [Abstract] [Full Text] [Related]

  • 3. Pubertal development and fertility in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Molgaard-Hansen L, Skou AS, Juul A, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology.
    Pediatr Blood Cancer; 2013 Dec 15; 60(12):1988-95. PubMed ID: 24038890
    [Abstract] [Full Text] [Related]

  • 4. Hearing Status in Survivors of Childhood Acute Myeloid Leukemia Treated With Chemotherapy Only: A NOPHO-AML Study.
    Skou AS, Olsen SØ, Nielsen LH, Glosli H, Jahnukainen K, Jarfelt M, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    J Pediatr Hematol Oncol; 2019 Jan 15; 41(1):e12-e17. PubMed ID: 30550508
    [Abstract] [Full Text] [Related]

  • 5. Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors.
    Mulder RL, Kremer LC, Koot BG, Benninga MA, Knijnenburg SL, van der Pal HJ, Koning CC, Oldenburger F, Wilde JC, Taminiau JA, Caron HN, van Dalen EC.
    Eur J Cancer; 2013 Jan 15; 49(1):185-93. PubMed ID: 22901831
    [Abstract] [Full Text] [Related]

  • 6. Cardiac function in survivors of childhood acute myeloid leukemia treated with chemotherapy only: a NOPHO-AML study.
    Jarfelt M, Andersen NH, Glosli H, Jahnukainen K, Jónmundsson GK, Malmros J, Nysom K, Hasle H, Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Eur J Haematol; 2016 Jul 15; 97(1):55-62. PubMed ID: 26383901
    [Abstract] [Full Text] [Related]

  • 7. Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
    Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Br J Haematol; 2010 Dec 15; 151(5):447-59. PubMed ID: 20955398
    [Abstract] [Full Text] [Related]

  • 8. Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO-AML) and review of the literature.
    Espersen ADL, Noren-Nyström U, Abrahamsson J, Ha SY, Pronk CJ, Jahnukainen K, Jónsson ÓG, Lausen B, Palle J, Zeller B, Palmqvist L, Hasle H.
    Genes Chromosomes Cancer; 2018 Jul 15; 57(7):359-365. PubMed ID: 29569294
    [Abstract] [Full Text] [Related]

  • 9. Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.
    Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Jacobsen BB.
    Leukemia; 1996 Aug 15; 10(8):1269-73. PubMed ID: 8709630
    [Abstract] [Full Text] [Related]

  • 10. Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials.
    Lie SO, Abrahamsson J, Clausen N, Forestier E, Hasle H, Hovi L, Jonmundsson G, Mellander L, Siimes MA, Yssing M, Zeller B, Gustafsson G, Nordic Society of Pediatric Hematology and Oncology (NOPHO), AML Study Group.
    Leukemia; 2005 Dec 15; 19(12):2090-100. PubMed ID: 16304571
    [Abstract] [Full Text] [Related]

  • 11. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
    Creutzig U, Büchner T, Sauerland MC, Zimmermann M, Reinhardt D, Döhner H, Schlenk RF.
    Cancer; 2008 Feb 01; 112(3):562-71. PubMed ID: 18076087
    [Abstract] [Full Text] [Related]

  • 12. Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
    Molgaard-Hansen L, Möttönen M, Glosli H, Jónmundsson GK, Abrahamsson J, Hasle H, Nordic Society of Paediatric Haematology and Oncology (NOPHO).
    Br J Haematol; 2011 Mar 01; 152(5):623-30. PubMed ID: 21241281
    [Abstract] [Full Text] [Related]

  • 13. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
    Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Lehrnbecher T.
    J Clin Oncol; 2004 Nov 01; 22(21):4384-93. PubMed ID: 15514380
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C, Hitzler J, Downie A, Montour-Proulx I, Alyman C, Cairney E, Spiegler BJ.
    Pediatr Blood Cancer; 2015 May 01; 62(5):854-8. PubMed ID: 25545182
    [Abstract] [Full Text] [Related]

  • 15. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.
    Ravindranath Y, Chang M, Steuber CP, Becton D, Dahl G, Civin C, Camitta B, Carroll A, Raimondi SC, Weinstein HJ, Pediatric Oncology Group.
    Leukemia; 2005 Dec 01; 19(12):2101-16. PubMed ID: 16136167
    [Abstract] [Full Text] [Related]

  • 16. Late effects in long-term survivors after treatment for childhood acute leukemia.
    Haddy TB, Mosher RB, Reaman GH.
    Clin Pediatr (Phila); 2009 Jul 01; 48(6):601-8. PubMed ID: 19264722
    [Abstract] [Full Text] [Related]

  • 17. The development of a novel protocol for the treatment of de novo childhood acute myeloid leukemia in a single institution in Taiwan.
    Yeh TC, Liu HC, Wang LY, Chen SH, Lin WY, Liang DC.
    J Pediatr Hematol Oncol; 2007 Dec 01; 29(12):826-31. PubMed ID: 18090930
    [Abstract] [Full Text] [Related]

  • 18. Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01.
    Løhmann DJA, Asdahl PH, Abrahamsson J, Ha SY, Jónsson ÓG, Kaspers GJL, Koskenvuo M, Lausen B, De Moerloose B, Palle J, Zeller B, Hasle H.
    Pediatr Blood Cancer; 2019 Jun 01; 66(6):e27701. PubMed ID: 30848067
    [Abstract] [Full Text] [Related]

  • 19. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
    Stefanski KJ, Anixt JS, Goodman P, Bowers K, Leisenring W, Scott Baker K, Burns K, Howell R, Davies S, Robison LL, Armstrong GT, Krull KR, Recklitis C.
    J Natl Cancer Inst; 2021 Apr 06; 113(4):481-495. PubMed ID: 32797189
    [Abstract] [Full Text] [Related]

  • 20. Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program.
    Barlogis V, Auquier P, Bertrand Y, Chastagner P, Plantaz D, Poiree M, Kanold J, Berbis J, Oudin C, Vercasson C, Allouche M, Tabone MD, Thouvenin-Doulet S, Saumet L, Chambost H, Baruchel A, Leverger G, Michel G.
    Haematologica; 2015 May 06; 100(5):e186-9. PubMed ID: 25616572
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.